Christopher UhdeSenior Pharma & Biotech Equity Analyst at SEBSpeaker
Profile
Senior Pharma & Biotech Equity Analyst at SEB since 2019. PhD in neurodevelopmental systems biology from Karolinska Institutet, and subsequently postdoctoral fellow at Karolinska in drug discovery for psychiatric disorders. Prior to joining SEB, was Biotech analyst at ABG Sundal Collier.
Agenda Sessions
“Mamma Mia”: Transatlantic reflections - assessing US policy impacts on the European biopharma ecosystem
, 15:45View Session